FHLC
HealthcareFidelity MSCI Health Care Index ETF
Fidelity · Tracks MSCI USA IMI Health Care 25/50 Index · Inception Oct 21, 2013
Trailing returns
through Oct 23, 2026- 1 year
- +26.6%
- 3 year
- +15.9%
- annualized
- 5 year
- +6.8%
- annualized
Price return from month-end closes, distributions reinvested at month end. Excludes trading costs, bid-ask spreads and taxes. Past performance says nothing about future returns and is not part of the composite score — see the methodology for what the score does measure.
Composite score
Based on a 0.084% expense ratio.
Based on $3.54B in net assets.
Top-10 holdings represent 51.9% of net assets.
Healthcare base · ETF wrapper · 1.18% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.2).
Look through FHLC, or compare the fee
Tool · Look-through
Underlying holdings, with other funds added
Add tickers and weights; N-PORT positions are summed across the basket.
Tool · Cost
Compare FHLC's fee against another fund
Compounds the 0.084% expense ratio against a peer over decades.
Tool · Overlap
Compare FHLC's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Healthcare funds.
Tool · TLH
Find a tax-loss harvesting partner for FHLC
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Asset location for FHLC across account types
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Eli Lilly & Co | 13.35% |
| 2 | Johnson & Johnson | 8.93% |
| 3 | AbbVie Inc | 6.42% |
| 4 | UnitedHealth Group Inc | 5.44% |
| 5 | Merck & Co Inc | 4.66% |
| 6 | Thermo Fisher Scientific Inc | 3.09% |
| 7 | Amgen Inc | 3.00% |
| 8 | Abbott Laboratories | 2.66% |
| 9 | Gilead Sciences Inc | 2.34% |
| 10 | Pfizer Inc | 2.06% |
Compare FHLC with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open FHLC at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.